Challenges in the Management of Relapsed/Refractory Multiple Myeloma | AJMC
Challenges in the Management of Relapsed/Refractory Multiple Myel…
2 months ago
ajmc.com
Evolving Evidence for CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma | CancerNetwork
Evolving Evidence for CAR T-Cell Therapy in Relapsed or Refractor…
2 months ago
cancernetwork.com
Triple-Class Exposed Relapsed and Refractory Multiple Myeloma | AJMC
Triple-Class Exposed Relapsed and Refractory Multiple Myeloma | AJMC
Jan 4, 2021
ajmc.com
Modern Relapsed Myeloma Population Is Addressed in MajesTEC-9 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Modern Relapsed Myeloma Population Is Addressed in Majes…
1 month ago
targetedonc.com
Relapsed/Refractory Multiple Myeloma: Optimal Therapy | OncLive
Relapsed/Refractory Multiple Myeloma: Optimal Therapy | OncLi…
Jan 17, 2019
onclive.com
Treatment for Relapsed/Refractory Multiple Myeloma
Treatment for Relapsed/Refractory Multiple Myeloma
Apr 28, 2017
onclive.com
Talquetamab for relapsed/refractory multiple myeloma: Results from a phase I study
Talquetamab for relapsed/refractory multiple myeloma: Results from a …
Jan 26, 2021
multiplemyelomahub.com
Dr. Yee on Treatment Considerations in Relapsed/Refra…
Apr 22, 2020
onclive.com
Treatment for relapsed myeloma
8 months ago
myeloma.org.uk
FDA Approves Daratumumab Plus Carfilzomib and Dexamethasone f…
Oct 9, 2020
ascopost.com
2:01
1.5K views · 40 reactions | The CAR T-cell therapy ide-cel is approved i…
1.5K views3 weeks ago
FacebookThe New England Journal of Medicine
Dr. Atrash on the BELLINI Trial Results in Relapsed/Refractory M…
Feb 4, 2020
onclive.com
Dr. Raje on Treatment Approaches for Relapsed/Refractory Myeloma …
2 months ago
onclive.com
Dr. Krishnan on Key Aspects of the ELOQUENT Trials in Relapsed/Ref…
1 week ago
onclive.com
Dr Fonseca on Selecting a Treatment in Relapsed/Refractory …
9 months ago
onclive.com
Dr. Larocca on Treatment Considerations for Difficult-to-Tre…
Jan 3, 2022
onclive.com
Dr Pan on the Novel Therapy Anito-Cel in Relapsed/Refractory Myelo…
7 months ago
onclive.com
Phase 2 Registrational Study of Anitocabtagene Autoleucel for th…
2 weeks ago
onclive.com
Dr Grajales-Cruz on Benefit With Teclistamab in Select Patients Wit…
Feb 27, 2024
onclive.com
Regeneron Pharmaceuticals, Inc.: Lynozyfic (linvoseltamab) Approv…
10 months ago
finanznachrichten.de
Future Treatment Considerations for Multiple Myeloma | OncLive
11 months ago
onclive.com
1:40
Despite the widespread use of immunomodulatory agents and pr…
20.9K viewsNov 7, 2018
FacebookThe New England Journal of Medicine
Dr Raza on Unmet Needs in R/R Myeloma With Extramedullary Dis…
5 months ago
onclive.com
2:51
Carfilzomib as maintenance therapy after upfront and salvage ASCT
128 viewsOct 17, 2021
multiplemyelomahub.com
26:07
Linvoseltamab (LYNOZYFIC ) - a BCMA x CD3 Bispecific Antibody f…
552 views3 weeks ago
YouTubeHealthTree University for Multiple Myeloma
4:03
Gintemetostat Breakthrough: Early Promise in Triple-Refractory Multi…
2 months ago
YouTubeTogether Anywhere
17:19
Relapsed/Refractory Multiple Myeloma — Microlearning Activit…
1 week ago
YouTubeResearch To Practice
37:11
Episode 401: Multiple Myeloma Treatment Considerations for Onc…
2 weeks ago
YouTubeOncology Nursing Society
2:15
CT0596 CAR-T Therapy Breakthrough for Multiple Myelom…
8 views2 months ago
YouTubeOne Planet Channel
1:43
ASH 2025 | CARTITUDE-4: Long-term PFS outcomes with cilta-cel f…
230 views2 months ago
YouTubeMultiple Myeloma Hub
See more videos
Static thumbnail place holder